TY - JOUR KW - Buprenorphine/therapeutic use KW - Humans KW - Opiate Substitution Treatment KW - Opioid-Related Disorders/drug therapy KW - Primary Health Care KW - Rural Population KW - opioid use disorder KW - Project ECHO KW - buprenorphine KW - medication assisted treatment KW - Medications for opioid use disorder KW - primary care KW - treatment retention rate AU - J. B. Anderson AU - S. A. Martin AU - A. Gadomski AU - N. Krupa AU - D. Mullin AU - A. Cahill AU - P. Jenkins A1 - AB -

Background: Our rural health system sought to (1) increase the number of primary care clinicians waivered to prescribe buprenorphine for treatment of opioid use disorder (OUD) and (2) consequently increase the number of our patients receiving this treatment. Methods: We used the Project for Extension for Community Health Outcomes (ECHO) tele-education model as an implementation strategy. We examined the number of clinicians newly waivered, the number of patients treated with buprenorphine, the relationship between clinician engagement with ECHO training and rates of buprenorphine prescribing, and treatment retention at 180 days. Results: The number of clinicians with a waiver and number of patients treated increased during and after ECHO training. There was a moderate correlation between the number of ECHO sessions attended by a clinician and number of their buprenorphine prescriptions (r = 0.50, p = 0.01). The 180-day retention rate was 80.7%. Conclusions: Project ECHO was highly effective for increasing access to this evidence-based treatment. The high retention rate in this rural context indicates that most patients are increasing their likelihood of favorable outcomes.

AD - Department of Medicine, Bassett Medical Center, Cooperstown, NY, USA.; Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA, USA.; UMassMemorial Healthcare, Worcester, MA, USA.; Bassett Medical Center, Bassett Research Institute, Cooperstown, NY, USA.; Bassett Medical Center, Bassett Research Institute, Cooperstown, NY, USA.; Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA, USA.; UMassMemorial Healthcare, Worcester, MA, USA.; Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA, USA.; Bassett Medical Center, Bassett Research Institute, Cooperstown, NY, USA. BT - Substance abuse C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use; HIT & Telehealth CP - 1 CY - United States DO - 10.1080/08897077.2021.1931633 IS - 1 JF - Substance abuse LA - eng M1 - Journal Article N2 -

Background: Our rural health system sought to (1) increase the number of primary care clinicians waivered to prescribe buprenorphine for treatment of opioid use disorder (OUD) and (2) consequently increase the number of our patients receiving this treatment. Methods: We used the Project for Extension for Community Health Outcomes (ECHO) tele-education model as an implementation strategy. We examined the number of clinicians newly waivered, the number of patients treated with buprenorphine, the relationship between clinician engagement with ECHO training and rates of buprenorphine prescribing, and treatment retention at 180 days. Results: The number of clinicians with a waiver and number of patients treated increased during and after ECHO training. There was a moderate correlation between the number of ECHO sessions attended by a clinician and number of their buprenorphine prescriptions (r = 0.50, p = 0.01). The 180-day retention rate was 80.7%. Conclusions: Project ECHO was highly effective for increasing access to this evidence-based treatment. The high retention rate in this rural context indicates that most patients are increasing their likelihood of favorable outcomes.

PP - United States PY - 2022 SN - 1547-0164; 0889-7077 SP - 222 EP - 230 EP - T1 - Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes T2 - Substance abuse TI - Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use; HIT & Telehealth U2 - 34086529 U3 - 10.1080/08897077.2021.1931633 VL - 43 VO - 1547-0164; 0889-7077 Y1 - 2022 ER -